Medical specialists from Israel tagged as investigators in clinical trials studying Chronic Lymphocytic Leukemia

Total 27 results

Abraham Avigdor
Seen in:
- HaMerkaz, Tel-Hashomer, The Chaim Sheba Medical Center
Trials:
- NCT02290951 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Non-Hodgkin Lymphoma
Ami Schattner, Prof.
Seen in:
- Holon, Wolfson MC
Trials:
- NCT00892827 (Sub-Investigator)
Conditions:
- Advanced Refractory Chronic Lymphocytic Leukemia
Arnon Nagler, MD
Seen in:
- Tel-Hashomer, Chaim Sheba Medical Center
Trials:
- NCT02507479 (Principal Investigator)
- NCT02488382 (Principal Investigator)
- NCT01991301 (Principal Investigator)
Conditions:
Avichai Shimoni, MD
Seen in:
- Tel-Hashomer, Chaim Sheba Medical Center
Trials:
- NCT02507479 (Sub-Investigator)
Conditions:
Galia Bartfeld-stemer
Seen in:
- Naharia, Health Corporation of Galilee Medical Center
Trials:
- NCT04965493 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Small Lymphocytic Lymphoma
Galia Stemmer
Seen in:
- Naharia, Galilee Medical Center
Trials:
- NCT04965493 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Small Lymphocytic Lymphoma
Gil Lugassy, Prof.
Seen in:
- Holon, Wolfson MC
Trials:
- NCT00892827 (Sub-Investigator)
Conditions:
- Advanced Refractory Chronic Lymphocytic Leukemia
Gilad Itchaki
Seen in:
- HaMerkaz, Petah Tikva, Rabin Medical Center
- HaMerkaz, Petah-Tikva, Rabin Medical Center
Trials:
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
Conditions:
Goldstein Daniela, MD
Seen in:
- Holon, Wolfson MC
Trials:
- NCT00892827 (Sub-Investigator)
Conditions:
- Advanced Refractory Chronic Lymphocytic Leukemia
Inna Tsoran Rosenthal
Seen in:
- Haifa, Rambam Health Care Campus - Hematology and Bone Marrow Transplantation Institute
Trials:
- NCT02290951 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Non-Hodgkin Lymphoma
Itay Levi
Seen in:
- Beer Sheva, Soroka Medical Center
Trials:
- NCT04666038 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Small Lymphocytic Lymphoma
Lev Shvidel
Seen in:
- Reẖovot, Kaplan Medical Center
Trials:
- NCT04965493 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Small Lymphocytic Lymphoma
Meir Preis
Seen in:
- Haifa, Carmel Medical Center
- Haifa, Lady Davis Carmel Medical Center
- Ḥeifā, Haifa, Carmel Hospital
Trials:
- NCT04797780 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT02290951 (Principal Investigator)
Conditions:
Merav Leiba
Seen in:
- Ashdod, Assuta Ashdod Medical Center
- Ashdod, GSK Investigational Site
- HaDarom, Ashdod, Assuta Ashdod University Hospital
Trials:
- NCT05556616 (Principal Investigator)
- NCT04484623 (Principal Investigator)
- NCT02290951 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
Michal Haran, MD
Seen in:
- Rehovot, Kaplan Medical Center
Trials:
- NCT00868478 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia
Neta Goldschmidt
Seen in:
- Jerusalem, Hadassah Medical Center
- Jerusalem, Hadassah University Hospital - Ein Kerem
- Yerushalayim, Hadassah University Hospital - Ein Kerem
- Yerushalayim, Jerusalem, Hadassah Medical Center
Trials:
- NCT05254743 (Principal Investigator)
- NCT02290951 (Principal Investigator)
- NCT05176691 (Principal Investigator)
- NCT04442022 (Principal Investigator)
Conditions:
Ohad Benjamini
Seen in:
- Ramat Gan, Chaim Sheba Medical Center
- Tel Hashomer, Sheba Medical Center
Trials:
- NCT05254743 (Principal Investigator)
- NCT05176691 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Leukemia, B-cell;
- Small Lymphocytic Lymphoma;
- Leukemia, Lymphocytic;
- Follicular Lymphoma;
- Waldenstrom Macroglobulinemia;
- Lymphoplasmacytic Lymphoma;
- NHL;
- DLBCL;
- Richter Syndrome;
- CLL/SLL;
- MCL;
- MZL
Rana Sabag
Seen in:
- Jerusalem, Hadassah Medical Center
Trials:
- NCT05254743 (Principal Investigator)
Conditions:
Riva Fineman
Seen in:
- Haifa, Rambam Health Care Campus
Trials:
- NCT05254743 (Principal Investigator)
Conditions:
Ronit Gurion
Seen in:
- Petach Tikva, Rabin Medical Center
- Petach-Tikva, Rabin Medical Center-Beilinson Campus
- Petah Tiqva, Rabin Medical Center
- Petah-Tikva, Rabin Medical Center-Beilinson Campus
Trials:
- NCT04965493 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT05176691 (Principal Investigator)
- NCT04442022 (Principal Investigator)
Conditions:
Shlomo Bulvik
Seen in:
- Netanya, Laniado Medical Center
Trials:
- NCT04666038 (Principal Investigator)
Conditions:
- Chronic Lymphocytic Leukemia;
- Small Lymphocytic Lymphoma
Tamar Tadmor
Seen in:
- Haifa, Bnai Zion Medical Center
- Haifa, Bnai-Zion Medical Center
Trials:
- NCT04662255 (Principal Investigator)
- NCT04797780 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04414475 (Principal Investigator)
Conditions:
Yair Herishanu
Seen in:
- Tel Aviv, Tel Aviv Sourasky Medical Center
Trials:
- NCT04662255 (Principal Investigator)
- NCT04965493 (Principal Investigator)
- NCT04666038 (Principal Investigator)
- NCT05254743 (Principal Investigator)
- NCT05176691 (Principal Investigator)
Conditions:

Clinical Trials on Chronic Lymphocytic Leukemia

National Heart, Lung, and Blood Institute (NHLBI)

Active, not recruiting

Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Leukemia, Lymphocytic, Chronic, B-Cell | Chronic Lymphocytic Leukemia | Leukemia, Chronic Lymphatic | B-Cell Chronic Lymphocytic Leukemia | Leukemia, Lymphocytic, Chronic | B-Lymphocytic Leukemia, Chronic | Leukemia, Chronic Lymphocytic, B-Cell | Lymphocytic Leukemia, Chronic, B Cell | Lymphocytic Leukemia...

United States
National Cancer Institute (NCI)

Completed

Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
National Cancer Institute (NCI)

Terminated

Obatoclax, Fludarabine, and Rituximab in Treating Patients With Previously Treated Chronic Lymphocytic Leukemia

Leukemia | B-cell Chronic Lymphocytic Leukemia | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Imprime PGG, Alemtuzumab, and Rituximab in Treating Patients With High Risk Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia

United States
National Cancer Institute (NCI)

Completed

Fludarabine, Rituximab, and Alemtuzumab in Treating Patients With Chronic Lymphocytic Leukemia

B-cell Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
National Cancer Institute (NCI)

Terminated

Sorafenib in Treating Patients With Relapsed Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
OHSU Knight Cancer Institute
Oregon Health and Science University

Completed

Dasatinib in Treating Patients With Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia

United States
Roswell Park Cancer Institute

Withdrawn

Azadirachta Indica in Treating Patients With Chronic Lymphocytic Leukemia

Refractory Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage III Chronic Lymphocytic Leukemia | Stage IV Chronic Lymphocytic Leukemia
Roswell Park Cancer Institute
National Cancer Institute (NCI); Celgene Corporation

Terminated

Lenalidomide as Chemoprevention in Treating Patients With High-Risk, Early-Stage B-Cell Chronic Lymphocytic Leukemia

Chronic Lymphocytic Leukemia | B-cell Chronic Lymphocytic Leukemia | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia

United States
Mayo Clinic
National Cancer Institute (NCI)

Completed

Ofatumumab, Pentostatin, and Cyclophosphamide in Treating Patients With Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Stage I Small Lymphocytic Lymphoma | Stage III Chronic Lymphocytic Leukemia and other conditions

United States

Medical specialists from Israel tagged as investigators in clinical trials studying Chronic Lymphocytic Leukemia

Clinical Trials on Chronic Lymphocytic Leukemia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Uzbekistan

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations